Safeguard Scientifics Announces Details for Investor Day 2011
This morning, we announced that planning is underway for Safeguard Scientifics Investor Day 2011. Join us at The Yale Club of New York City on…
Posted by
This morning, we announced that planning is underway for Safeguard Scientifics Investor Day 2011. Join us at The Yale Club of New York City on…
Posted by
Baltimore-based company provides home sleep tests for the diagnosis of obstructive sleep apnea Wayne, PA, June 27, 2011 – Safeguard Scientifics, Inc. (NYSE: SFE), a holding…
Posted by
Last week, Safeguard Scientifics’ Life Sciences team attended J.P. Morgan’s 29th Annual Healthcare Conference and OneMedForumSF 2011 (video) in San Francisco. Our main takeaway is that…
Posted by
This week, our life sciences team is heading out to San Francisco to attend J.P. Morgan’s 29th Annual Healthcare Conference, one of the life science…
Posted by
Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…
Posted by
At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…
Posted by
Thank you to those who were able to attend Safeguard Scientifics’ Investor Day 2010 either in person or via webcast. For those of you were…
Posted by
Just a quick reminder that Safeguard Scientifics’ Investor Day 2010 event will be held next Tuesday, October 5, from 8:00 a.m. – 11:30 a.m. at…
Posted by
Today, we were honored by the Philadelphia Business Journal with the Inaugural Life Sciences Venture Impact Award, which “goes to the venture capital firm from…
Posted by